Model
Edge
Recursion Pharmaceuticals, Inc.
RXRX
Filing type
4
Filing date
Sep 9, 2026
Updated
Sep 10, 2026 ยท 3:55 PM
Copy reference
Filing
4
Statement of Changes in Beneficial Ownership